Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment
byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e
Updated on: January 02,2024
12
Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment
byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e
Updated on:January 02,2024
12
